Zhang XY,Varthi M,Sykes SM,et al.The putative cancer stem cell marker USP22is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression[J].Mol Cell,2008,29(1):102-111.
Atanassov BS,Dent SY.USP22regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1[J].EMBO Rep,2011,12(9):924-930.
[4]
Yang M,Liu YD,Wang YY,et al.Ubiquitin-specific protease 22:a novel molecular biomarker in cervical cancer prognosis and therapeutics[J].Tumour Biol,2014,35(2):929-934.
Sussman RT,Stanek TJ,Esteso P,et al.The epigenetic modifier ubiquitin-specific protease 22(USP22)regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2(SOX2)[J].J Biol Chem,2013,288(33):24 234-24 246.
[7]
Lee HJ,Kim MS,Shin JM,et al.The expression patterns of deubiquitinating enzymes,USP22and Usp22[J].Gene Expr Patterns,2006,6(3):277-284.
[8]
Xiong J,Che X,Li X,et al.Cloning and Characterization of the Human USP22 Gene Promoter[J].PLoS One,2012,7(12):e52716.
[9]
Havemann D,Balakrishnan M,Borahay M,et al.Intermedin/adrenomedullin 2is associated with implantation and placentation via trophoblastinvasion in human pregnancy[J].J Clin Endocrinol Metab,2013,98(2):695-703.
[10]
Kapoor S.Usp22and its evolving role in systemic carcinogenesis[J].Lung Cancer,2013,79(2):191.
